Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports from Sweden and Ireland describe recent advances in breast cancer research
May 10th, 2006
Data on breast cancer are outlined in reports from Sweden and Ireland. Study 1: Formyl-Met-Asp-Gly-Cys-Glu-Leu peptide ligand demonstrated a potential use in antimetastatic treatment of breast cancer. "Loss of Wnt-5a protein expression is associated with shorter recurrence-free survival in breast carcinoma patients and increased motility in mammary cell lines. Based on sequence analysis of Wnt-5a, we identified 14 peptide fragments and investigated their ability to mimic the effects of Wnt-5a on mammary cell adhesion and migration," scientists in Sweden reported. "Two of these peptides significantly increased adhesion and impaired...
Source: Vaccine Weekly (2006-05-10)
|
